Iovance Biotherapeutics

Iovance Biotherapeutics, based in Philadelphia, specializes in developing investigational therapies utilizing tumor infiltrating lymphocytes (TIL) and peripheral blood lymphocytes (PBL) for cancer treatment. Their focus includes ongoing clinical trials and a promising pipeline of innovative treatments.

With a dedication to advancing cancer care, Iovance Biotherapeutics offers cutting-edge TIL and PBL therapies aimed at improving patient outcomes. Their commitment to research and development is evident through their robust clinical trial program and pipeline of potential breakthrough treatments.

Generated from their website's infomation